Boston Scientific Looking To Expand Urology/Gynecology Product Offerings
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific remains open to the possibility of making an acquisition in the urology or gynecology area to boost the current 8-10% rate of revenue growth.
You may also be interested in...
Boston Scientific Adds To Carotid Pipeline With Endotex Nexstent
Patient enrollment for a clinical trial evaluating Boston Scientific's Filterwire distal protection device with Endotex Interventional Systems' Nexstent carotid stent should begin by year-end.
Cook Looks To Reach Zenith In Endovascular AAA Market With Q3 PMA Filing
Cook, Inc. anticipates filing a premarket approval application with FDA in the third quarter of 2001 for its Zenith endovascular abdominal aortic aneurysm (AAA) graft, positioning the firm to become the third player in the endovascular AAA market behind Medtronic and Guidant.
Medtronic GuardWire Begins Controlled Roll-Out In U.S. Market
Medtronic PercuSurge is planning to submit an IDE application in the next two months for a 500-600 patient trial evaluating its GuardWire distal protection device in patients with acute myocardial infarction.